Proof of Concept
-
Local sirolimus (rapamycin) infusion for 30 days in non-human primates with implanted ePTFE rats elicited a dramatic 80% reduction in vessel thickening at one month.
-
Termination of the sirolimus infusion at 30 days led to rapid reformation of the stenotic lesion at 90 days, indicating continual drug administration is required.
